About this trial
This study looks at a new digital art therapy program for young adult cancer survivors. It focuses on how well the ARTCan Therapy App works and if it is a suitable way to provide art therapy. Participants will use the app for six weeks, following weekly art prompts and answering questions about their mental health. The goal is to see if this therapy can help improve their quality of life.
This trial is identified by NCT06789666. It does not involve drugs or devices regulated by the FDA. The study aims to include about 15 participants.
Who can join
Young adults aged 18 to 25 who have survived cancer can join this study. They need to be willing to participate and have access to the internet and a device like a computer or smartphone. Participants must also have mood issues and be interested in making art. The study team will check to make sure everyone meets these requirements.
Conditions
Cancer, Pediatric Cancer, Pediatric Malignancies, Pediatric Sarcoma of Soft Tissue, Adolescent and Young Adult With Brain Cancer
The study team makes the final call on eligibility.
What happens in the study
All participants will take part in the digital art therapy program using the ARTCan App for six weeks. They will complete weekly art projects and answer surveys about their mental health. This information will help the therapist understand their progress and experience.
Where
This trial is running at 1 location in the United States. It is currently recruiting.
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina